Drug Approval | May 20, 2023
Granules India received ANDA approval for Venlafaxine ER capsules
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions
Farxiga is expected to have such a strong influence on the market due to the impressive results
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
The facility will have a capacity to manufacture upto 3 million tubes monthly
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Subscribe To Our Newsletter & Stay Updated
